SEC Form 3 · accession 0001104659-15-031951
Blueprint Medicines Corp · BPMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kyle D. Kuvalanka
Officer — Chief Business Officer
Period of report
Apr 30, 2015
Accepted (ET)
Apr 30, 2015 · 7:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 33,670 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.48 | holding | — | — | — | — | Sep 17, 2023 | Common Stock | 102,693 | — | D |
| Stock Option (Right to Buy)F2 | $1.87 | holding | — | — | — | — | Aug 14, 2024 | Common Stock | 14,545 | — | D |
| Stock Option (Right to Buy)F3 | $8.80 | holding | — | — | — | — | Feb 10, 2025 | Common Stock | 36,363 | — | D |
Explanation of responses
- F1This option vests over a four-year period, at a rate of twenty-five percent (25%) on September 16, 2014 and in 36 equal monthly installments thereafter.
- F2This option vests in 48 equal monthly installments beginning on August 18, 2014.
- F3This option vests in 48 equal monthly installments beginning on February 10, 2015.